LGVN - After yesterday's breather Longeveron short squeeze continues; shares up 122%

The apparent short squeeze that began last week in Longeveron (LGVN +122.3%) is continuing today as the share price has more than doubled. The stock took a breather yesterday, closing down 29%. Longeveron was initially boosted on Nov. 18 after the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome. The stock has been discussed heavily on social media by investors who noted its low float and high short interest.

For further details see:

After yesterday's breather, Longeveron short squeeze continues; shares up 122%